Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 10-Q, Date: 2013-05-15, XBRL Interactive Financials
Original SEC Filing: Click here

---

Webplus: SKBI/20130515/10-Q/1/000.htm SEC Original: v344542_10q.htm
SKYSTAR BIO-PHARMACEUTICALMPANY FORM10-Q INDEX Page No. PART I.FINANCIAL INFORMATION Item 1.ndensednsolidated Financial Statements 3ndensednsolidated Balance Sheets of March 31, 2013 (unaudited) and December 31, 2012 3ndensednsolidated Statements ofmprehensiveome for the Three Months Ended March 31, 2013 and 2012 (unaudited) 4ndensednsolidated Statements ofsh Flows for the Three Months Ended March 31, 2013 and 2012(unaudited)

---

---

Webplus: SKBI/20130515/10-Q/2_EX-31.1/000.htm SEC Original: v344542_ex31-1.htm
SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q ofystar Bio-Pharmaceuticalmpany; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light

---

---

Webplus: SKBI/20130515/10-Q/3_EX-31.2/000.htm SEC Original: v344542_ex31-2.htm
SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q ofystar Bio-Pharmaceuticalmpany; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light

---

---

Webplus: SKBI/20130515/10-Q/4_EX-32.1/000.htm SEC Original: v344542_ex32-1.htm
18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and result of operations of thempany at thetes and for the periods indicated. May 15, 2013 Weibing Lu Chief Executive Officer

---

---

Webplus: SKBI/20130515/10-Q/5_EX-32.2/000.htm SEC Original: v344542_ex32-2.htm
18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and result of operations of thempany at thetes and for the periods indicated. May 15, 2013 Bing Mei Chief Financial Officer

---

Company Information:

Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 10-Q, Date: 2013-05-15, XBRL Interactive FinancialsCIK: 0001076939, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
RM 10601, JIEZUO PLAZA, NO. 4, FENGHUI ROAD SOUTH, GAOXIN DISTRICT
XIAN PROVINCE